摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Chloro-quinoline-3-sulfonic acid dimethylamide | 157494-14-9

中文名称
——
中文别名
——
英文名称
4-Chloro-quinoline-3-sulfonic acid dimethylamide
英文别名
4-chloro-N,N-dimethylquinoline-3-sulfonamide
4-Chloro-quinoline-3-sulfonic acid dimethylamide化学式
CAS
157494-14-9
化学式
C11H11ClN2O2S
mdl
——
分子量
270.74
InChiKey
UKNZMNKPUCDVKC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    58.6
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-Chloro-quinoline-3-sulfonic acid dimethylamide盐酸 作用下, 反应 0.5h, 以79%的产率得到4-Oxo-1,4-dihydro-quinoline-3-sulfonic acid dimethylamide
    参考文献:
    名称:
    The Preparation of 1-Nonsubstituted and 1-Methyl- (and Ethyl)-1,4-dihydro-4-oxo- 3-quinolinesulfonamides from 4-Chloro-3-quinolinesulfonamides
    摘要:
    DOI:
    10.3987/com-97-7887
  • 作为产物:
    描述:
    参考文献:
    名称:
    Synthesis and Amination of 4-Chloro-3-quinolinesulfonyl Chloride
    摘要:
    Chlorinolysis of 4-chloro-3-benzylthioquinoline (2) or thioquinanthrene (1) using chlorine gas in the presence of water gave 4-chloro-3-quinolinesulfonyl chloride (3). Amination of (3) performed in ether led to 4-chloro-3-quinolinesulfonamides (4). Reactions of compound (3) with an excess of primary or secondary amine in two phase (water/toluene or benzene) system gave 4-(substituted amino)-3-quinolinesulfonamides (5) with two identical amine rests. While 4-chloro-3-quinolinesulfonamides (4) were aminated with an excess of amine into aminosulfonamides (5) with two identical or two various amine rests.
    DOI:
    10.3987/com-94-6683
点击查看最新优质反应信息

文献信息

  • HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS, IN PARTICULAR AS ANTI-ALZHEIMER AGENTS
    申请人:Marsais Francis
    公开号:US20090062279A1
    公开(公告)日:2009-03-05
    The invention is related to compound which comprises at least one radical C═Y, Y being O or S, and an oxidable and non protonable nitrogen atom N wherein the distance (d) between the at least one carbon atom of the radical group C═Y and the nitrogen atom, when oxidized, is comprised between 0.3 and 0.8 nanometers. The invention is related to new heterocyclic compounds defined by formula G, their preparation, to pharmaceutical compositions comprising them and to their use as therapeutic agents, particularly in the treatment of neurodegenerative or Alzheimer disease.
    本发明涉及一种化合物,其包含至少一个基团C═Y,其中Y为O或S,以及一个可氧化且不可质子化的氮原子N,其中在氧化时,基团C═Y的至少一个碳原子与氮原子之间的距离(d)在0.3至0.8纳米之间。本发明涉及由公式G定义的新杂环化合物及其制备方法,涉及包含它们的制药组合物以及它们在治疗神经退行性或阿尔茨海默病方面的用途。
  • New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
    申请人:Institut National des Sciences Appliquees de Rouen (INSA)
    公开号:EP1731507A1
    公开(公告)日:2006-12-13
    The invention is related to compound which comprises at least one radical C=Y, Y being O or S, and an oxidable and non protonable nitrogen atom N wherein the distance (d) between the at least one carbon atom of the radical group C=Y and the nitrogen atom, when oxidized, is comprised between 0.3 and 0.8 nanometers. The invention is related to new heterocyclic compounds defined by formula G, their preparation, to pharmaceutical compositions comprising them and to their use as therapeutic agents, particularly in the treatment of neurodegenerative or Alzheimer disease.
    本发明涉及由至少一个基团C=Y(Y为O或S)和一个可氧化且不可质子化的氮原子N组成的化合物,其中基团C=Y的至少一个碳原子与氮原子之间的距离(d)在氧化时介于0.3至0.8纳米之间。 本发明涉及由式 G 定义的新杂环化合物、 它们的制备、包含它们的药物组合物以及它们作为治疗剂的用途,特别是在治疗神经退行性疾病或阿尔茨海默病中的用途。
  • NEW HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS, IN PARTICULAR AS ANTI-ALZHEIMER AGENTS
    申请人:Insa Rouen
    公开号:EP1868998A2
    公开(公告)日:2007-12-26
  • US7977354B2
    申请人:——
    公开号:US7977354B2
    公开(公告)日:2011-07-12
  • [EN] NEW HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS, IN PARTICULAR AS ANTI-ALZHEIMER AGENTS<br/>[FR] NOUVEAUX COMPOSES HETEROCYCLIQUES, PREPARATION ET UTILISATION EN TANT QUE MEDICAMENTS, NOTAMMENT EN TANT QU'AGENTS ANTI-ALZHEIMER
    申请人:INSA ROUEN
    公开号:WO2006103120A2
    公开(公告)日:2006-10-05
    [EN] The invention is related to compound which comprises at least one radical C=Y, Y being O or S, and an oxidable and non protonable nitrogen atom N wherein the distance (d) between the at least one carbon atom of the radical group C=Y and the nitrogen atom, when oxidized, is comprised between 0.3 and 0.8 nanometers. The invention is related to new heterocyclic compounds defined by formula G, their preparation, to pharmaceutical compositions comprising them and to their use as therapeutic agents, particularly in the treatment of neurodegenerative or Alzheimer disease.
    [FR] L'invention concerne des composés contenant au moins un radical C=Y, Y étant O ou S, et un atome d'azote N oxydable ou non protonable, la distance (d) entre le ou les atomes de carbone du groupe radical C=Y et l'atome d'azote, si oxydé, étant comprise entre 0,3 et 0,8 nm. L'invention concerne également de nouveaux composés hétérocycliques représentés par la formule G, leur préparation, des compositions pharmaceutiques les contenant et leur utilisation en tant qu'agents thérapeutiques, notamment dans le traitement de maladies neurodégénératives ou de la maladie d'Alzheimer.
查看更多